Abiopharma

News list

EVERTEC, INC. (EVTC)

SEC News
May 06, 2026, 20:07 UTC

(30% Negative) EVERTEC, INC. (EVTC) Reports Q2 2026 Financial Results

Full text

News bot May 6, 2026, 8:16 p.m.

📋 EVERTEC, INC. (EVTC) - Financial Results

Filing Date: 2026-05-06

Accepted: 2026-05-06 16:07:46

Event Type: Financial Results

Event Details:

EVERTEC, INC. (EVTC) Reports the reporting period Financial Results EVERTEC, INC. (EVTC) announced its financial results for the period ending the reporting period. Key Financial Highlights:

Revenue: 1060
Net Income: 56049
EPS: 3.81
Cash and equivalents: 328453

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2026	2025	Change ($)	Change (%)
Revenue	247.92K	247.92K	$0.00	+0.00%
Operating Costs And Expenses Total Operating Expenses	203.35K	179.29K	$24.06K	+13.42%
Nonoperating Income Expenses Interest Income	3.86K	3.25K	$609.00	+18.73%
Nonoperating Income Expenses Interest Expense	-17.36K	-16.99K	$-369.00	-2.17%
Nonoperating Income Expenses Other Income Net	187.00	220.00	$-33.00	-15.00%
Current Assets Prepaid Expenses Other Current Assets	83.67K	68.46K	$15.20K	+22.21%
Current Assets Property Equipment Net	65.76K	64.35K	$1.41K	+2.18%
Current Assets Operating Lease Right Of Use Assets	37.03K	38.22K	$-1.19K	-3.12%
Current Liabilities Accrued Liabilities	116.50K	116.50K	$0.00	+0.00%
Current Liabilities Accounts Payable	63.35K	63.73K	$-371.00	-0.58%
Current Liabilities Other Long Term Liabilities	31.93K	34.32K	$-2.38K	-6.95%
Prepaid Expenses Other Current Assets	-7.95K	-9.40K	$1.46K	+15.51%
Operating Lease Liabilities	-1.22K	-1.40K	$176.00	+12.59%
Other Long Term Liabilities	1.20K	183.00	$1.01K	+554.10%
Interest Expense	13.50K	13.74K	$-240.00	-1.75%
Noncontrolling Interests	-2.71K	-398.00	$-2.31K	-581.41%

💼 Business Developments:

Partnership
Acquisition
Licensing: Not available
Regulatory Approval: Not available
Executive Changes: Not available

Structured Data:

Company Name: EVERTEC, INC.
Ticker Symbol: EVTC